Latest News about SGMO
Recent news which mentions SGMO
From Benzinga
 
   7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
   
  
  
  April 16, 2023
  From InvestorPlace
 
   Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
   
  
  
  April 14, 2023
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Monday
   
  
  
  April 10, 2023
  From Benzinga
 
   The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
   
  
  
  March 25, 2023
  From InvestorPlace
 From Benzinga
 
   UBS Group, Credit Suisse And Other Big Stocks Moving Lower In Monday's Pre-Market Session
   
  
  
  March 20, 2023
  From Benzinga
 From Benzinga
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  March 15, 2023
  From Benzinga
 
   10 Companies That Had Tons of Money in SVB When It Collapsed
   
  
  
  March 13, 2023
  From InvestorPlace
 
   Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
   
  
  
  March 11, 2023
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
   
  
  
  February 27, 2023
  From Benzinga
 
   12 Health Care Stocks Moving In Monday's Pre-Market Session
   
  
  
  February 27, 2023
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Friday
   
  
  
  February 24, 2023
  From Benzinga
 
   Sangamo Therapeutics Shares Updated Data From Fabry Gene Therapy Study, Says It Shows Evidence Of Clinical Benefit
   
  February 23, 2023
  Tickers 
   SGMO
  
  
  From Benzinga
 
   Earnings Scheduled For February 22, 2023
   
  
  
  February 22, 2023
  From Benzinga
 
   Why Bionano Genomics, Pacific Biosciences of California, and Sangamo Therapeutics Stocks Crumbled This Week
   
  
  
  February 10, 2023
  From Motley Fool
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  December 28, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  December 22, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Wednesday
   
  
  
  December 21, 2022
  From Benzinga
 
   Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment
   
  
  
  November 29, 2022
  From Benzinga
 
   Earnings Scheduled For November 3, 2022
   
  
  
  November 03, 2022
  From Benzinga
 From Benzinga
 
   Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
   
  
  
  September 23, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

